---
figid: PMC7368878__13568_2020_1064_Fig1_HTML
figtitle: Metabolism of cyclophosphamide
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7368878
filename: 13568_2020_1064_Fig1_HTML.jpg
figlink: pmc/articles/PMC7368878/figure/Fig1/
number: F1
caption: Metabolism of cyclophosphamide. The activation pathway requires hydroxylation
  of CPA by the human cytochrome P450 system (especially CYP2B6, -2C19 and -3A4).
  The primary metabolite 4-OH-CPA is in equilibrium with its tautomer aldophosphamide
  (APA) that undergoes -elimination to the final toxic metabolites phosphoramide mustard
  (PAM) and acrolein. Through an oxidative reaction catalyzed by alcohol dehydrogenases
  (ADH) and particularly aldehyde dehydrogenase 1 (ALDH1), 4-OH-CPA and APA are irreversibly
  deactivated.Figure adapted from de Jonge et al. (de Jonge et al. )
papertitle: Synthesis of cyclophosphamide metabolites by a peroxygenase from Marasmius
  rotula for toxicological studies on human cancer cells.
reftext: Susanne Steinbrecht, et al. AMB Express. 2020;10:128.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9342344
figid_alias: PMC7368878__F1
figtype: Figure
redirect_from: /figures/PMC7368878__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7368878__13568_2020_1064_Fig1_HTML.html
  '@type': Dataset
  description: Metabolism of cyclophosphamide. The activation pathway requires hydroxylation
    of CPA by the human cytochrome P450 system (especially CYP2B6, -2C19 and -3A4).
    The primary metabolite 4-OH-CPA is in equilibrium with its tautomer aldophosphamide
    (APA) that undergoes -elimination to the final toxic metabolites phosphoramide
    mustard (PAM) and acrolein. Through an oxidative reaction catalyzed by alcohol
    dehydrogenases (ADH) and particularly aldehyde dehydrogenase 1 (ALDH1), 4-OH-CPA
    and APA are irreversibly deactivated.Figure adapted from de Jonge et al. (de Jonge
    et al. )
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cyp4g1
  - Cyp4d1
  - Cyp4d2
  - Cyp4ae1
  - Cyp18a1
  - Cpr
  - Cyp4e3
  - Cyp6a2
  - Cyp9b1
  - Cyp9b2
  - Cyp4e2
  - Cyp6a9
  - Cyp6a20
  - Cyp6a21
  - Cyp6a8
  - Cyp9c1
  - Cyp4d8
  - Cyp12a4
  - Cyp4c3
  - Cyp4e1
  - Cyp4p1
  - Cyp6a22
  - ci
  - cpa
  - en
  - Sap-r
  - Adh
  - Hn
  - CYP2B6
  - PAM
  - MYCBP2
  - CPA1
  - ENPEP
  - CYP3A4
  - AVP
  - ADH1A
  - ADH1B
  - ADH1C
  - ADH4
  - ADH5
  - ADH6
  - ADH7
  - ADHFE1
  - ALDH1A1
  - KLK8
  - 4-hydroxycyclophosphamide
  - 4-OH-CPA
  - phosphoramide
  - cyclophosphamide
  - CPA
  - aldophosphamide
  - chloroacetaldehyde
  - acrolein
  - 2-dechloroethylcyclophosphamide
  - 4-ketocyclophosphamide
  - 4-keto-CPA
  - carboxyphosphamide
  - O=d-O
---
